UNAIDS chief Winnie Byanyima expressed concern over the loss of American funding for HIV efforts, calling it 'devastating' and potentially life-threatening for vulnerable populations. She proposed a deal to US President Trump to allow Gilead to produce its prevention drug lenacapavir globally, which could significantly reduce HIV infections. Byanyima highlighted the critical role of US funding in UNAIDS' budget and warned of severe consequences if support is not restored, including millions of additional deaths and infections.